Abstract
This report describes a GLC assay for carbamazepine in plasma. The procedure involves the selective extraction of carbamazepine from phenobarbital and diphenylhydantoin. Carbamazepine is stabilized for quantitation in GLC through the formation of its trimethylsilyl derivative. The sensitivity of the method is sufficient to quantitate blood levels in patients receiving carbamazepine for seizure disorders.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
